CMZ TABLETS
Natural health product licensed in Canada
- Licence holder
- Pharmaline Inc.
- NPN or DIN-HM
- 80004537
- Status
- Active licence
- Licence date
- 15 November 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium | 500 mg | Not calculated |
| Magnésium | 250 mg | Not calculated |
Non-medicinal ingredients
Povidone, Amidon de maïs, Eau, Dioxyde de silicium, Cellulose - microcrystalline, Phosphate de calcium, dibasique, anhydre, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | Not specified |
Uses authorised in Canada
Helps to maintain good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Take with food. Avoid using two hours prior to or until four (4) hours after taking other medications. Consult a healthcare practitioner prior use if you are taking tetracyclines. Zinc supplementation can cause a copper deficiency. Consult a healthcare practitioner if you are unsure whether or not you are taking adequate copper.
Source
Official Health Canada record, licence 80004537
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.